CUA Educational Content

Evolving Treatment Paradigms in Advanced Urothelial Carcinoma

Featuring: Shilpa Gupta (Taussig Cancer Institute, Cleveland Clinic Foundation)

By participating in this program, participants can expect to:

  • review of latest evidence for treatment of advanced urothelial cancer
  • discuss the perspective on multidisciplinary approaches to optimize first line SOC treatments of chemotherapy and immunotherapy
  • gain insight on new approaches/research to further advance standard first-line treatment options for advanced urothelial carcinoma


This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.


This program has received financial support from EMD Serono and Pfizer in the form of an educational grant.